Models to study NMO disease mechanisms and new therapies.

Investigator: Alan Verkman, MD, PhD
Sponsor: Guthy-Jackson Charitable Foundation

Location(s): United States


The research utilizes expertise in animal models, drug screening and development, and advanced imaging methods. A central goal is the discovery and advancement of novel Neuromyelitis optica (NMO) therapeutics, which necessitates ancillary studies of efficacy in animal models and elucidation of NMO pathogenesis mechanisms.